Evidence map›Paper›PMID 39196315›Full record

Trial reportSleep & breathing = Schlaf & Atmung2024

Remote monitoring system to support positive airway pressure therapy in patients with obstructive sleep apnea: a multi-center randomized controlled trial.

Shokoufeh Aalaei, Hamed Tabesh, Hadi Shahraki, Fariborz Rezaeitalab, Mahnaz Amini, Lahya Afsharisaleh, Hadi Asadpour, Saeid Eslami

Abstract readRandomized Controlled TrialMulticenter Study
PubMed Publisher
In one paragraph

Trial report in Sleep & breathing = Schlaf & Atmung, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shokoufeh AalaeiDepartment of Medical Informatics, School of Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, 91779-48564, Iran.
Hamed TabeshDepartment of Medical Informatics, School of Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, 91779-48564, Iran.
Hadi ShahrakiDepartment of Computer Engineering, Faculty of Industry and Mining, University of Sistan and Baluchestan, Zahedan, Iran.
Fariborz RezaeitalabDepartment of Neurology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mahnaz AminiLung Diseases Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Lahya AfsharisalehDepartment of Occupational Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Hadi AsadpourSleep Laboratory of Ibn-E-Sina Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Saeid EslamiDepartment of Medical Informatics, School of Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, 91779-48564, Iran. s.eslami.h@gmail.com.ORCID 0000-0003-3755-1212

Funding

Mashhad University of Medical Sciences 950994
6 · The paper itself

Abstract

purposeTo develop and evaluate an intervention tailored to patients' needs to increase the rate of positive airway pressure (PAP) adherence in patients afflicted with obstructive sleep apnea (OSA), who undergo PAP therapy.

methodsA multi-center, 3 parallel-arm, randomized, controlled trial was conducted. Participants with OSA who undergo a PAP therapy were randomized to one of three groups: control arm (usual care), educational booklet arm, and mobile-based application arm. PAP usage, the percentage of days using the device for more than 4 h, change in knowledge, risk perception, outcome expectancy, self-efficacy, and ESS were assessed before and one month after interventions in the three groups. Also, the application usage data were analyzed.

resultsThe result showed the change in average PAP usage, knowledge, risk perception, and self-efficacy in the application group was significantly higher than the control and booklet groups. Also, the change in use for more than 4 h in the application group was significantly higher than the control group. Comparing the actual and patients' self-report PAP use indicated patients' self-report about the use of the device is about 50 min (0.8 h) more than the actual amount of use.

conclusionThe study results indicated that the improvement of primary and secondary outcomes in adherence to PAP was significantly higher in the application group than in other study groups. Given the increasingly penetrating influence of smartphone-based technologies, it seems that mobile-based applications could potentially be adopted in the population of patients with OSA. CLINICAL TRIALS REGISTRATION: IRCT2017092236314N1; https://en.irct.ir/trial/27185.

Indexed as

Continuous Positive Airway PressureMonitoring, PhysiologicRemote ConsultationSleep Apnea, ObstructiveAdultFemaleHumansMaleMiddle AgedMobile ApplicationsPatient CompliancePatient Education as TopicInformation technologyMobile healthObstructive sleep apneaPatient adherencePatient educationPositive airway pressureSelf-efficacyTelemedicineTelemonitoring

Identifiers

PMID39196315

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.